A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache

A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache

Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a small study. Using a nebulizer to administer the drug would improve the feasibility of using the treatment. It would also spare the patient narcotics with their attendant side effects. Because of the potential for placebo effect a placebo control is necessary in this study.

Inclusion Criteria:

• Meets IHS criteria for migraine

Exclusion Criteria:

• Pregnant
• Breast feeding
• Allergic to Lidocaine
• Worst or first Headache
• Abnormal neurological exam
• Substance abuse within 6 months
• Cardiac, liver or pulmonary disease
• Participation n another study within 30 days